Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Collegium Pharmaceutical, Inc. (COLL)
USD35.95
+0.93 (+2.65%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
100 Technology Center Drive 2072
Stoughton, MA, US
Stoughton, MA, US
CEO
Vikram Karnani
Website
collegiumpharma.com
IPO
2015-05-07
CIK 1267565 ISIN US19459J1043
Description
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respectively. Founded in 2002, the enterprise initially operated under the name Collegium Pharmaceuticals, Inc., before officially adopting its current identity as Collegium Pharmaceutical, Inc. in October 2003. The company's corporate headquarters are situated in Stoughton, Massachusetts.
News Sentiment (7d)
3 articles
- Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD35.95
+0.93 (+2.65%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
460.9K
Beta
0.75
Float Shares
31.39M
Free Float %
96.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.34% | -4.83% | +0.62% | -21.18% | -24.63% | -22.92% | +20.74% | +54.70% | +63.42% | +137.77% | +190.40% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
35.95
Low
56.00
+55.8%
Consensus
58.00
+61.3%
Median
58.00
+61.3%
High
60.00
+66.9%
DCF (Unlevered)
657.48
+1,729.1%
DCF (Levered)
875.89
+2,336.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
83% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
58.00
+61.3%
|
| Last Year | 5 |
57.40
+59.7%
|
| All Time | 13 |
47.31
+31.6%
|
Quality scores
Altman Z-Score
1.71
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+23.6% ★ Q1'26: +8.9% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-7.0% Q1'26: +443.5% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+37.3% ★ Q1'26: +29.4% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+22.4% ★ Q1'26: +16.5% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+14.2% ★ Q1'26: +14.2% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%-1.8% ★ Q1'26: +22.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×2.35× Q1'26: 2.30× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 4 Rev. Ana. 1 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.71M
est: 2.28M (-25.1%)
|
28.48M
est: 27.64M (+3.0%)
|
280.41M
est: 279.61M (+0.3%)
|
296.70M
est: 295.82M (+0.3%)
|
310.02M
est: 311.22M (-0.4%)
|
276.87M
est: 332.37M (-16.7%)
|
463.93M
est: 459.50M (+1.0%)
|
566.77M
est: 576.65M (-1.7%)
|
631.45M
est: 629.25M (+0.3%)
|
780.57M
est: 781.49M (-0.1%)
|
818.62M
782.52M – 852.25M
+4.8% YoY
|
856.19M
818.44M – 891.36M
+4.6% YoY
|
604.60M
577.94M – 629.44M
-29.4% YoY
|
741.80M
709.09M – 772.27M
+22.7% YoY
|
767.90M
734.04M – 799.45M
+3.5% YoY
|
| EBITDA |
-93.43M
est: 982.6K (-9,608.1%)
|
-74.27M
est: 11.90M (-724.3%)
|
91.91M
est: 122.02M (-24.7%)
|
-6.33M
est: -4.36M (-45.3%)
|
118.01M
est: 120.52M (-2.1%)
|
86.56M
est: 75.24M (+15.0%)
|
173.31M
est: 102.69M (+68.8%)
|
308.33M
est: 263.54M (+17.0%)
|
341.70M
est: 287.58M (+18.8%)
|
401.01M
est: 357.15M (+12.3%)
|
374.12M
357.62M – 389.49M
+4.8% YoY
|
391.29M
374.04M – 407.37M
+4.6% YoY
|
276.31M
264.13M – 287.66M
-29.4% YoY
|
339.01M
324.06M – 352.94M
+22.7% YoY
|
350.94M
335.47M – 365.36M
+3.5% YoY
|
| EBIT |
-94.08M
est: 399.0K (-23,679.9%)
|
-74.87M
est: 4.83M (-1,649.7%)
|
-19.00M
est: 2.23M (-950.3%)
|
-21.81M
est: -22.42M (+2.7%)
|
56.46M
est: 54.48M (+3.6%)
|
17.64M
est: -21.54M (+181.9%)
|
34.37M
est: -65.13M (+152.8%)
|
159.07M
est: 105.62M (+50.6%)
|
172.54M
est: 115.25M (+49.7%)
|
174.93M
est: 143.14M (+22.2%)
|
149.94M
143.33M – 156.10M
+4.8% YoY
|
156.82M
149.91M – 163.26M
+4.6% YoY
|
110.74M
105.86M – 115.29M
-29.4% YoY
|
135.87M
129.88M – 141.45M
+22.7% YoY
|
140.65M
134.45M – 146.43M
+3.5% YoY
|
| Net Income |
-94.18M
est: -159.68M (+41.0%)
|
-74.87M
est: -102.16M (+26.7%)
|
-39.13M
est: -16.24M (-141.0%)
|
-22.72M
est: -21.38M (-6.3%)
|
26.75M
est: 23.54M (+13.7%)
|
71.52M
est: 54.01M (+32.4%)
|
-25.00M
est: -11.16M (-124.0%)
|
48.16M
est: 121.06M (-60.2%)
|
69.19M
est: 244.98M (-71.8%)
|
62.87M
est: 296.59M (-78.8%)
|
296.76M
289.90M – 303.62M
+0.1% YoY
|
282.36M
200.95M – 363.76M
-4.9% YoY
|
260.07M
245.64M – 274.49M
-7.9% YoY
|
369.42M
348.25M – 389.15M
+42.1% YoY
|
393.25M
370.70M – 414.25M
+6.4% YoY
|
| SGA |
80.63M
est: 793.9K (+10,056.7%)
|
92.76M
est: 9.61M (+865.0%)
|
126.76M
est: 154.63M (-18.0%)
|
116.45M
est: 118.84M (-2.0%)
|
113.83M
est: 131.44M (-13.4%)
|
118.96M
est: 163.05M (-27.0%)
|
172.19M
est: 274.76M (-37.3%)
|
159.21M
est: 198.98M (-20.0%)
|
182.98M
est: 217.13M (-15.7%)
|
276.17M
est: 269.66M (+2.4%)
|
282.47M
270.02M – 294.08M
+4.8% YoY
|
295.44M
282.41M – 307.57M
+4.6% YoY
|
208.62M
199.43M – 217.19M
-29.4% YoY
|
255.97M
244.68M – 266.48M
+22.7% YoY
|
264.97M
253.29M – 275.86M
+3.5% YoY
|
| EPS |
-3.88
est: -3.95 (+1.8%)
|
-2.47
est: -2.53 (+2.3%)
|
-1.19
est: -1.34 (+10.9%)
|
-0.24
est: 0.14 (-266.3%)
|
0.78
est: 3.75 (-79.2%)
|
2.05
est: 3.84 (-46.6%)
|
-0.74
est: 4.33 (-117.1%)
|
1.60
est: 3.06 (-47.6%)
|
2.14
est: 6.18 (-65.4%)
|
1.98
est: 7.47 (-73.5%)
|
7.48
7.30 – 7.65
+0.1% YoY
|
7.11
5.06 – 9.16
-4.9% YoY
|
6.56
6.19 – 6.91
-7.7% YoY
|
9.31
8.77 – 9.80
+41.8% YoY
|
9.91
9.34 – 10.43
+6.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
336.18M
OE per share TTM
8.50
Owner's Yield
26.64%
Maintenance CapEx ratio
3.37%
Maint CapEx / Avg PPE
4.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
80
Total invested
127.91M
Insider transactions (90d)
0
Beneficial owners (>5%)
29
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 5.63M | 16.30% | 5.55M | — | 5.63M | — | HC | Delaware | 2022-01-28 | ↗ |
| 2 | EIN #00-0000000 | 3.77M | 10.90% | — | 3.77M | — | 3.77M | IA, HC | Jersey, Channel Islands | 2022-02-10 | ↗ |
| 3 | Eventide Asset Management, LLC | 2.63M | 7.60% | 2.63M | — | 2.63M | — | IA | Delaware | 2022-02-14 | ↗ |
| 4 | Finny Kuruvilla, M.D. Ph. D. | 2.63M | 7.60% | — | 2.63M | — | — | HC, IN | Delaware | 2022-02-14 | ↗ |
| 5 | Robin C. John | 2.63M | 7.60% | — | 2.63M | — | — | HC, IN | Delaware | 2022-02-14 | ↗ |
| 6 | David Rosen | 2.61M | 7.54% | — | 2.61M | — | — | IN | Delaware | 2022-02-14 | ↗ |
| 7 | LP | 2.61M | 7.54% | — | 2.61M | — | — | IA, PN | Delaware | 2022-02-14 | ↗ |
| 8 | 10. | 2.56M | 7.70% | 2.56M | — | 2.56M | — | IC | Sydney, New South Wales Australia | 2019-02-14 | ↗ |
| 9 | The Vanguard Group - 23-1945930 | 2.29M | 6.62% | — | 73.3K | 2.19M | 96.1K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 10 | Rubric Capital Management LP | 1.93M | 5.57% | — | 1.93M | — | 1.93M | IA, PN | State of Delaware | 2021-02-16 | ↗ |
| 11 | Principal Global Investors, LLC | 1.75M | 5.42% | — | 1.75M | — | — | IA | Delaware | 2024-11-13 | ↗ |
| 12 | 1,721,722 | 1.72M | 5.00% | — | 1.72M | — | 1.72M | IN | Delaware | 2020-04-22 | ↗ |
| 13 | 84-1521705 | 1.30M | 3.80% | — | 1.30M | — | 1.30M | IV | Massachusetts | 2022-02-10 | ↗ |
| 14 | Alan Frazier | 1.13M | 3.40% | — | 1.13M | — | 11.00 | IN | — | 2020-01-24 | ↗ |
| 15 | FHM VI, L.L.C. | 1.13M | 3.40% | — | 1.13M | — | 11.00 | OO | — | 2020-01-24 | ↗ |
| 16 | FHM VI, L.P. | 1.13M | 3.40% | — | 1.13M | — | 11.00 | PN | — | 2020-01-24 | ↗ |
| 17 | James Topper | 1.13M | 3.40% | — | 1.13M | — | 11.00 | IN | — | 2020-01-24 | ↗ |
| 18 | Nader Naini | 1.13M | 3.40% | — | 1.13M | — | 11.00 | IN | — | 2020-01-24 | ↗ |
| 19 | Nathan Every | 1.13M | 3.40% | — | 1.13M | — | 11.00 | IN | — | 2020-01-24 | ↗ |
| 20 | Patrick Heron | 1.13M | 3.40% | — | 1.13M | — | 11.00 | IN | — | 2020-01-24 | ↗ |
| 21 | Frazier Healthcare VI, L.P. | 943.7K | 2.80% | — | 943.7K | — | 11.00 | PN | — | 2020-01-24 | ↗ |
| 22 | Delaware Smid Cap Growth Fund, a series of Delaware Group Equity Funds IV | — | 0.00% | — | — | — | — | IC | Delaware | 2020-02-13 | ↗ |
| 23 | IV | — | 0.00% | — | — | — | — | IC | State of Delaware | 2020-02-13 | ↗ |
| 24 | Macquarie Bank Limited | — | 0.00% | — | — | — | — | CO | Sydney, New South Wales, Australia | 2020-02-13 | ↗ |
| 25 | Macquarie Funds Management Hong Kong Limited | — | 0.00% | — | — | — | — | CO | Hong Kong | 2020-02-13 | ↗ |
| 26 | Macquarie Group Limited | — | 0.00% | — | — | — | — | HC | Sydney, New South Wales Australia | 2020-02-13 | ↗ |
| 27 | Macquarie Investment Management Business Trust | — | 0.00% | — | — | — | — | IA | Delaware | 2020-02-13 | ↗ |
| 28 | Macquarie Investment Management Holdings Inc | — | 0.00% | — | — | — | — | HC | State of Delaware | 2020-02-13 | ↗ |
| 29 | Perceptive Advisors LLC | — | 0.00% | — | — | — | — | IA | Delaware | 2022-02-15 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
80
-198 vs prev Q
New positions
13
Closed positions
210
Increased
38
Reduced
26
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 5.10M -78.3K (-1.5%) | 236.12M +54.9M (+30.3%) | 16.15% -0.125 pp | 0.00% +0.001 pp | USD38.58 +20.0% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 2.26M +29.9K (+1.3%) | 104.46M +26.6M (+34.1%) | 7.15% +0.148 pp | 0.00% +0.000 pp | USD20.22 +129.0% | 43 qtrs — |
| 3 | EVENTIDE ASSET MANAGEMENT, LLC | 1.88M -514.7K (-21.5%) | 86.88M +3.2M (+3.9%) | 5.94% -1.573 pp | 1.36% -0.018 pp | USD18.21 +154.3% | 43 qtrs — |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 1.62M +18.2K (+1.1%) | 74.88M +18.9M (+33.8%) | 5.12% +0.096 pp | 0.12% +0.042 pp | USD22.64 +104.5% | 27 qtrs — |
| 5 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.50M -2.6K (-0.2%) | 69.45M +16.9M (+32.1%) | 4.75% +0.028 pp | 0.23% +0.056 pp | USD37.27 +24.2% | 8 qtrs — |
| 6 | RUBRIC CAPITAL MANAGEMENT LP | 1.50M -1.3M (-47.1%) | 69.28M -29.6M (-29.9%) | 4.74% -4.146 pp | 0.83% -0.287 pp | USD26.14 +77.1% | 24 qtrs — |
| 7 | JANUS HENDERSON GROUP PLC | 1.45M +538.3K (+59.1%) | 67.03M +35.2M (+110.6%) | 4.59% +1.727 pp | 0.03% +0.016 pp | USD37.56 +23.3% | 33 qtrs — |
| 8 | PRINCIPAL FINANCIAL GROUP INC | 1.31M +3.9K (+0.3%) | 60.82M +15.0M (+32.7%) | 4.16% +0.044 pp | 0.03% +0.008 pp | USD22.36 +107.1% | 21 qtrs — |
| 9 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.31M +518.7K (+65.3%) | 60.78M +33.0M (+118.8%) | 4.16% +1.662 pp | 0.02% +0.011 pp | USD32.15 +44.0% | 43 qtrs — |
| 10 | STATE STREET CORP | 1.31M +16.7K (+1.3%) | 60.68M +15.4M (+34.0%) | 4.15% +0.084 pp | 0.00% +0.001 pp | USD21.86 +111.8% | 43 qtrs — |
| 11 | INVESCO LTD. | 1.18M -107.9K (-8.4%) | 54.40M +9.5M (+21.2%) | 3.72% -0.311 pp | 0.01% +0.001 pp | USD24.92 +85.8% | 25 qtrs — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 830.5K -611.0 (-0.1%) | 38.45M +9.4M (+32.2%) | 2.63% +0.018 pp | 0.01% +0.002 pp | USD19.24 +140.6% | 35 qtrs — |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 829.5K -6.9K (-0.8%) | 38.41M +9.1M (+31.2%) | 2.63% -0.002 pp | 0.00% +0.001 pp | USD21.14 +119.0% | 42 qtrs — |
| 14 | MORGAN STANLEY | 684.6K -82.8K (-10.8%) | 31.70M +4.8M (+18.0%) | 2.17% -0.244 pp | 0.00% +0.000 pp | USD27.29 +69.7% | 43 qtrs — |
| 15 | D. E. SHAW & CO., INC. | 653.9K +264.1K (+67.8%) | 30.27M +16.6M (+122.0%) | 2.07% +0.846 pp | 0.02% +0.009 pp | USD37.72 +22.7% | 18 qtrs — |
| 16 | GOLDMAN SACHS GROUP INC | 647.5K -154.7K (-19.3%) | 29.98M +1.9M (+6.8%) | 2.05% -0.471 pp | 0.00% +0.000 pp | USD33.86 +36.7% | 43 qtrs — |
| 17 | EMERALD ADVISERS, LLC | 629.3K -10.4K (-1.6%) | 29.14M +6.8M (+30.2%) | 1.99% -0.018 pp | 0.90% +0.180 pp | USD24.56 +88.5% | 25 qtrs — |
| 18 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 543.8K +510.1K (+1,512.9%) | 25.18M +24.0M (+2,034.3%) | 1.72% +1.616 pp | 0.01% +0.014 pp | USD45.60 +1.5% | 2 qtrs — |
| 19 | ASSENAGON ASSET MANAGEMENT S.A. | 511.7K +316.1K (+161.6%) | 23.69M +16.8M (+246.2%) | 1.62% +1.006 pp | 0.03% +0.023 pp | USD41.11 +12.6% | 16 qtrs — |
| 20 | MARSHALL WACE, LLP | 492.4K +213.3K (+76.5%) | 22.80M +13.0M (+133.5%) | 1.56% +0.682 pp | 0.02% +0.011 pp | USD38.39 +20.6% | 3 qtrs — |
| 21 | VICTORY CAPITAL MANAGEMENT INC | 457.3K -22.4K (-4.7%) | 21.17M +4.4M (+26.2%) | 1.45% -0.060 pp | 0.01% +0.002 pp | USD26.51 +74.7% | 31 qtrs — |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 447.3K +40.4K (+9.9%) | 20.71M +6.5M (+45.5%) | 1.42% +0.138 pp | 0.00% +0.001 pp | USD27.03 +71.3% | 41 qtrs — |
| 23 | EMERALD MUTUAL FUND ADVISERS TRUST | 391.7K -4.0K (-1.0%) | 18.13M +4.3M (+31.0%) | 1.24% -0.003 pp | 0.88% +0.169 pp | USD24.41 +89.7% | 25 qtrs — |
| 24 | TWO SIGMA INVESTMENTS, LP | 366.1K +96.8K (+35.9%) | 16.95M +7.5M (+79.9%) | 1.16% +0.313 pp | 0.02% +0.010 pp | USD37.24 +24.3% | 13 qtrs — |
| 25 | NORTHERN TRUST CORP | 353.6K -17.7K (-4.8%) | 16.37M +3.4M (+26.0%) | 1.12% -0.047 pp | 0.00% +0.000 pp | USD18.77 +146.7% | 42 qtrs — |
| 26 | LSV ASSET MANAGEMENT | 347.9K +1.3K (+0.4%) | 16.11M +4.0M (+32.8%) | 1.10% +0.012 pp | 0.04% +0.008 pp | USD34.63 +33.7% | 18 qtrs — |
| 27 | LOOMIS SAYLES & CO L P | 332.6K +14.7K (+4.6%) | 15.40M +4.3M (+38.4%) | 1.05% +0.054 pp | 0.02% +0.005 pp | USD30.46 +52.0% | 11 qtrs — |
| 28 | QUBE RESEARCH & TECHNOLOGIES LTD | 268.2K -52.3K (-16.3%) | 12.42M +1.2M (+10.7%) | 0.85% -0.158 pp | 0.01% +0.001 pp | USD33.50 +38.2% | 12 qtrs — |
| 29 | ROYCE & ASSOCIATES LP | 251.2K -55.0K (-18.0%) | 11.63M +916.5K (+8.6%) | 0.80% -0.167 pp | 0.12% +0.011 pp | USD33.65 +37.6% | 10 qtrs — |
| 30 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 247.7K -1.8K (-0.7%) | 11.47M +2.7M (+31.4%) | 0.78% +0.000 pp | 0.04% +0.011 pp | USD34.42 +34.5% | 3 qtrs — |
| 31 | PACER ADVISORS, INC. | 240.9K -9.7K (-3.9%) | 11.15M +2.4M (+27.2%) | 0.76% -0.025 pp | 0.03% +0.006 pp | USD29.07 +59.3% | 13 qtrs — |
| 32 | BANK OF NEW YORK MELLON CORP | 227.1K -21.9K (-8.8%) | 10.52M +1.8M (+20.7%) | 0.72% -0.063 pp | 0.00% +0.000 pp | USD21.62 +114.2% | 43 qtrs — |
| 33 | BNP PARIBAS ARBITRAGE, SNC | 219.5K +105.1K (+91.8%) | 10.16M +6.2M (+153.8%) | 0.70% +0.336 pp | 0.00% +0.003 pp | USD40.26 +15.0% | 42 qtrs — |
| 34 | AMERICAN CENTURY COMPANIES INC | 207.1K +89.1K (+75.5%) | 9.59M +5.5M (+132.3%) | 0.66% +0.285 pp | 0.00% +0.003 pp | USD37.25 +24.3% | 24 qtrs — |
| 35 | HILLSDALE INVESTMENT MANAGEMENT INC. | 206.6K +3.6K (+1.8%) | 9.57M +2.5M (+34.7%) | 0.65% +0.016 pp | 0.26% +0.050 pp | USD28.83 +60.6% | 12 qtrs — |
| 36 | THIRD AVENUE MANAGEMENT LLC | 203.4K +— (+0.0%) | 9.42M +2.3M (+31.6%) | 0.64% +0.005 pp | 1.71% +0.369 pp | USD32.24 +43.6% | 9 qtrs — |
| 37 | BANK OF AMERICA CORP /DE/ | 195.3K -50.4K (-20.5%) | 9.04M +445.1K (+5.2%) | 0.62% -0.154 pp | 0.00% +0.000 pp | USD31.06 +49.1% | 43 qtrs — |
| 38 | JANE STREET GROUP, LLC | 190.8K -50.0K (-20.8%) | 8.83M +409.2K (+4.9%) | 0.60% -0.153 pp | 0.00% +0.000 pp | USD33.46 +38.4% | 12 qtrs — |
| 39 | TREXQUANT INVESTMENT LP | 150.6K +150.6K (+100.0%) | 6.97M +7.0M (+100.0%) | 0.48% +0.477 pp | 0.06% +0.062 pp | USD46.30 +0.0% | 1 qtrs NEW |
| 40 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 146.7K +23.8K (+19.3%) | 6.79M +2.5M (+57.9%) | 0.46% +0.078 pp | 0.02% +0.007 pp | USD31.38 +47.5% | 20 qtrs — |
| 41 | CITADEL ADVISORS LLC | 131.1K -122.4K (-48.3%) | 6.07M -2.8M (-31.6%) | 0.42% -0.382 pp | 0.00% 0.000 pp | USD30.03 +54.2% | 36 qtrs — |
| 42 | BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 130.5K -4.8K (-3.5%) | 6.04M +1.3M (+27.6%) | 0.41% -0.012 pp | 0.04% +0.008 pp | USD26.36 +75.6% | 26 qtrs — |
| 43 | WELLINGTON MANAGEMENT GROUP LLP | 115.4K -7.6K (-6.2%) | 5.34M +1.0M (+24.2%) | 0.37% -0.021 pp | 0.00% +0.000 pp | USD36.67 +26.3% | 8 qtrs — |
| 44 | NORGES BANK | 112.5K +112.5K (+100.0%) | 5.21M +5.2M (+100.0%) | 0.36% +0.356 pp | 0.00% +0.001 pp | USD46.30 +0.0% | 1 qtrs NEW |
| 45 | UNIPLAN INVESTMENT COUNSEL, INC. | 111.7K -289.0 (-0.3%) | 5.17M +1.3M (+32.0%) | 0.35% +0.002 pp | 0.52% +0.136 pp | USD24.93 +85.7% | 10 qtrs — |
| 46 | BALLAST ASSET MANAGEMENT, LP | 110.4K -3.9K (-3.4%) | 5.11M +1.1M (+27.8%) | 0.35% -0.010 pp | 2.42% +0.590 pp | USD30.86 +50.0% | 3 qtrs — |
| 47 | INTECH INVESTMENT MANAGEMENT LLC | 108.9K +22.1K (+25.5%) | 5.04M +2.0M (+66.1%) | 0.34% +0.072 pp | 0.05% +0.018 pp | USD33.24 +39.3% | 6 qtrs — |
| 48 | JPMORGAN CHASE & CO | 108.0K -103.7K (-49.0%) | 5.00M -2.4M (-32.5%) | 0.34% -0.324 pp | 0.00% 0.000 pp | USD34.32 +34.9% | 36 qtrs — |
| 49 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 105.2K +89.4K (+565.6%) | 4.87M +4.3M (+780.8%) | 0.33% +0.284 pp | 0.04% +0.033 pp | USD44.60 +3.8% | 12 qtrs — |
| 50 | BARCLAYS PLC | 103.6K +28.6K (+38.0%) | 4.80M +1.9M (+65.4%) | 0.33% +0.092 pp | 0.00% +0.000 pp | USD36.44 +27.1% | 43 qtrs — |
| 51 | AQR CAPITAL MANAGEMENT LLC | 101.3K +14.1K (+16.1%) | 4.69M +1.6M (+53.7%) | 0.32% +0.047 pp | 0.00% +0.001 pp | USD29.34 +57.8% | 31 qtrs — |
| 52 | RHUMBLINE ADVISERS | 96.2K -8.5K (-8.1%) | 4.46M +792.0K (+21.6%) | 0.30% -0.024 pp | 0.00% +0.001 pp | USD21.22 +118.2% | 39 qtrs — |
| 53 | UBS GROUP AG | 95.9K -159.6K (-62.5%) | 4.44M -4.5M (-50.3%) | 0.30% -0.499 pp | 0.00% -0.001 pp | USD30.68 +50.9% | 42 qtrs — |
| 54 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 92.4K -3.5K (-3.6%) | 4.29M +932.4K (+27.8%) | 0.29% -0.009 pp | 0.01% +0.001 pp | USD28.69 +61.4% | 5 qtrs — |
| 55 | LEGAL & GENERAL GROUP PLC | 77.5K -1.4K (-1.7%) | 3.59M +828.8K (+30.0%) | 0.25% -0.003 pp | 0.00% +0.000 pp | USD22.84 +102.7% | 39 qtrs — |
| 56 | PRUDENTIAL FINANCIAL INC | 75.5K +29.8K (+65.3%) | 3.50M +1.9M (+118.7%) | 0.24% +0.096 pp | 0.00% +0.002 pp | USD34.26 +35.1% | 20 qtrs — |
| 57 | CREDIT AGRICOLE S A | 73.4K +73.4K (+100.0%) | 3.40M +3.4M (+100.0%) | 0.23% +0.233 pp | 0.01% +0.008 pp | USD46.30 +0.0% | 1 qtrs NEW |
| 58 | AMERIPRISE FINANCIAL INC | 73.0K -573.0 (-0.8%) | 3.38M +805.3K (+31.3%) | 0.23% 0.000 pp | 0.00% +0.000 pp | USD27.11 +70.8% | 27 qtrs — |
| 59 | ALGERT GLOBAL LLC | 70.6K +13.6K (+23.9%) | 3.27M +1.3M (+64.0%) | 0.22% +0.045 pp | 0.05% +0.018 pp | USD37.17 +24.6% | 2 qtrs — |
| 60 | MILLENNIUM MANAGEMENT LLC | 70.3K -51.9K (-42.5%) | 3.25M -1.0M (-23.9%) | 0.22% -0.162 pp | 0.00% -0.001 pp | USD29.08 +59.2% | 15 qtrs — |
| 61 | NUVEEN, LLC | 69.1K -3.0K (-4.2%) | 3.20M +676.2K (+26.8%) | 0.22% -0.008 pp | 0.00% +0.000 pp | USD29.85 +55.1% | 4 qtrs — |
| 62 | BESSEMER GROUP INC | 66.2K +66.0K (+27,151.0%) | 3.07M +3.1M (+33,966.7%) | 0.21% +0.209 pp | 0.00% +0.005 pp | USD46.27 +0.1% | 8 qtrs — |
| 63 | SWISS NATIONAL BANK | 62.3K +— (+0.0%) | 2.88M +704.6K (+32.3%) | 0.20% +0.002 pp | 0.00% +0.001 pp | USD17.45 +165.3% | 39 qtrs — |
| 64 | JUMP FINANCIAL, LLC | 60.5K -18.0K (-23.0%) | 2.80M +53.2K (+1.9%) | 0.19% -0.055 pp | 0.03% +0.002 pp | USD34.99 +32.3% | 4 qtrs — |
| 65 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 60.3K -2.2K (-3.6%) | 2.79M +603.9K (+27.6%) | 0.19% -0.006 pp | 0.02% +0.003 pp | USD33.60 +37.8% | 12 qtrs — |
| 66 | FMR LLC | 59.9K +1.0K (+1.7%) | 2.77M +712.0K (+34.6%) | 0.19% +0.005 pp | 0.00% +0.000 pp | USD34.41 +34.6% | 21 qtrs — |
| 67 | CITIGROUP INC | 58.9K -27.7K (-32.0%) | 2.73M -302.9K (-10.0%) | 0.19% -0.086 pp | 0.00% 0.000 pp | USD31.67 +46.2% | 43 qtrs — |
| 68 | WEDGE CAPITAL MANAGEMENT L L P/NC | 58.3K +58.3K (+100.0%) | 2.70M +2.7M (+100.0%) | 0.18% +0.185 pp | 0.05% +0.048 pp | USD46.30 +0.0% | 1 qtrs NEW |
| 69 | WELLS FARGO & COMPANY/MN | 57.6K +35.2K (+157.5%) | 2.67M +1.9M (+240.7%) | 0.18% +0.112 pp | 0.00% +0.000 pp | USD41.32 +12.1% | 43 qtrs — |
| 70 | EASTERN BANK | 54.8K +— (+0.0%) | 2.54M +620.3K (+32.3%) | 0.17% +0.001 pp | 0.04% +0.010 pp | USD32.98 +40.4% | 13 qtrs — |
| 71 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 54.8K -100.3K (-64.6%) | 2.54M -2.9M (-53.2%) | 0.17% -0.314 pp | 0.01% -0.010 pp | USD29.75 +55.6% | 4 qtrs — |
| 72 | RAYMOND JAMES FINANCIAL INC | 53.6K +8.2K (+18.0%) | 2.48M +892.2K (+56.1%) | 0.17% +0.027 pp | 0.00% +0.000 pp | USD31.86 +45.3% | 5 qtrs — |
| 73 | UBS ASSET MANAGEMENT AMERICAS INC | 53.5K -3.5K (-6.2%) | 2.48M +481.7K (+24.1%) | 0.17% -0.010 pp | 0.00% +0.000 pp | USD27.56 +68.0% | 31 qtrs — |
| 74 | TWO SIGMA ADVISERS, LP | 53.0K -49.5K (-48.3%) | 2.45M -1.1M (-31.6%) | 0.17% -0.154 pp | 0.00% -0.002 pp | USD32.65 +41.8% | 31 qtrs — |
| 75 | GLOBEFLEX CAPITAL L P | 53.0K +— (+0.0%) | 2.45M +598.9K (+32.3%) | 0.17% +0.001 pp | 0.38% +0.090 pp | USD20.48 +126.1% | 27 qtrs — |
| 76 | ENGINEERS GATE MANAGER LP | 50.3K -2.0K (-3.9%) | 2.33M +497.0K (+27.2%) | 0.16% -0.005 pp | 0.03% +0.007 pp | USD29.22 +58.5% | 10 qtrs — |
| 77 | F/M INVESTMENTS LLC | 50.0K -4.0K (-7.4%) | 2.32M +426.4K (+22.6%) | 0.16% -0.011 pp | 0.09% +0.015 pp | USD28.73 +61.2% | 5 qtrs — |
| 78 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 48.8K +34.0K (+230.3%) | 2.26M +1.7M (+337.1%) | 0.15% +0.108 pp | 0.03% +0.027 pp | USD42.06 +10.1% | 3 qtrs — |
| 79 | HRT FINANCIAL LP | 48.7K +48.7K (+100.0%) | 2.25M +2.3M (+100.0%) | 0.15% +0.154 pp | 0.01% +0.007 pp | USD46.30 +0.0% | 1 qtrs NEW |
| 80 | MAN GROUP PLC | 48.5K -45.5K (-48.4%) | 2.24M -1.0M (-31.7%) | 0.15% -0.142 pp | 0.00% -0.002 pp | USD34.51 +34.2% | 11 qtrs — |
| 81 | SEI INVESTMENTS CO | 44.8K +32.5K (+265.0%) | 2.07M +1.6M (+383.3%) | 0.14% +0.103 pp | 0.00% +0.002 pp | USD41.04 +12.8% | 24 qtrs — |
| 82 | JEFFERIES FINANCIAL GROUP INC. | 44.2K -82.3K (-65.0%) | 2.05M -2.4M (-53.7%) | 0.14% -0.258 pp | 0.01% -0.010 pp | USD34.99 +32.3% | 2 qtrs — |
| 83 | STATE OF WISCONSIN INVESTMENT BOARD | 42.0K +840.0 (+2.0%) | 1.94M +504.3K (+35.0%) | 0.13% +0.004 pp | 0.00% +0.001 pp | USD32.27 +43.5% | 35 qtrs — |
| 84 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 41.2K +41.2K (+100.0%) | 1.91M +1.9M (+100.0%) | 0.13% +0.131 pp | 0.00% +0.003 pp | USD46.30 +0.0% | 1 qtrs NEW |
| 85 | CAMPBELL & CO INVESTMENT ADVISER LLC | 40.0K +20.8K (+108.5%) | 1.85M +1.2M (+175.8%) | 0.13% +0.066 pp | 0.09% +0.038 pp | USD38.41 +20.5% | 4 qtrs — |
| 86 | WALLEYE CAPITAL LLC | 39.7K -189.5K (-82.7%) | 1.84M -6.2M (-77.1%) | 0.13% -0.595 pp | 0.01% -0.024 pp | USD34.99 +32.3% | 2 qtrs — |
| 87 | JACKSON CREEK INVESTMENT ADVISORS LLC | 38.8K +28.2K (+263.9%) | 1.80M +1.4M (+381.0%) | 0.12% +0.090 pp | 0.53% +0.423 pp | USD44.19 +4.8% | 8 qtrs — |
| 88 | MARTINGALE ASSET MANAGEMENT L P | 38.2K +6.7K (+21.3%) | 1.77M +665.6K (+60.5%) | 0.12% +0.022 pp | 0.04% +0.017 pp | USD35.12 +31.8% | 16 qtrs — |
| 89 | FRANKLIN RESOURCES INC | 37.8K +6.9K (+22.2%) | 1.75M +666.9K (+61.7%) | 0.12% +0.022 pp | 0.00% +0.000 pp | USD29.53 +56.8% | 11 qtrs — |
| 90 | ADVISOR GROUP HOLDINGS, INC. | 37.0K +36.6K (+7,678.6%) | 1.71M +1.7M (+9,824.2%) | 0.12% +0.116 pp | 0.00% +0.003 pp | USD46.10 +0.4% | 24 qtrs — |
| 91 | PRICE T ROWE ASSOCIATES INC /MD/ | 36.0K +1.1K (+3.0%) | 1.67M +445.0K (+36.4%) | 0.11% +0.004 pp | 0.00% +0.000 pp | USD23.20 +99.6% | 33 qtrs — |
| 92 | QUANTBOT TECHNOLOGIES LP | 35.8K -15.4K (-30.1%) | 1.66M -133.8K (-7.5%) | 0.11% -0.048 pp | 0.06% +0.006 pp | USD33.92 +36.5% | 4 qtrs — |
| 93 | ENVESTNET ASSET MANAGEMENT INC | 35.7K -13.2K (-27.0%) | 1.65M -57.9K (-3.4%) | 0.11% -0.041 pp | 0.00% +0.000 pp | USD27.59 +67.8% | 24 qtrs — |
| 94 | ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 35.7K -384.0 (-1.1%) | 1.65M +390.0K (+30.9%) | 0.11% 0.000 pp | 0.24% +0.050 pp | USD22.90 +102.2% | 25 qtrs — |
| 95 | INTEGRATED QUANTITATIVE INVESTMENTS LLC | 35.5K +26.9K (+315.4%) | 1.64M +1.3M (+449.7%) | 0.11% +0.086 pp | 0.35% +0.268 pp | USD42.05 +10.1% | 5 qtrs — |
| 96 | EASTERLY INVESTMENT PARTNERS LLC | 35.1K -16.3K (-31.7%) | 1.63M -172.3K (-9.6%) | 0.11% -0.050 pp | 0.10% -0.022 pp | USD25.36 +82.6% | 16 qtrs — |
| 97 | ALLIANCEBERNSTEIN L.P. | 35.0K -1.0K (-2.8%) | 1.62M +361.0K (+28.6%) | 0.11% -0.002 pp | 0.00% +0.000 pp | USD21.19 +118.5% | 39 qtrs — |
| 98 | EMPOWERED FUNDS, LLC | 32.7K +32.7K (+100.0%) | 1.51M +1.5M (+100.0%) | 0.10% +0.103 pp | 0.01% +0.012 pp | USD46.30 +0.0% | 1 qtrs NEW |
| 99 | QUEST PARTNERS LLC | 32.0K +7.0K (+27.9%) | 1.48M +605.2K (+69.2%) | 0.10% +0.023 pp | 0.08% +0.026 pp | USD36.95 +25.3% | 8 qtrs — |
| 100 | LOS ANGELES CAPITAL MANAGEMENT LLC | 40.4K -26.8K (-39.9%) | 1.44M -911.0K (-38.7%) | 0.13% -0.083 pp | 0.00% -0.003 pp | USD23.68 +95.5% | 24 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 156 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco Pharmaceuticals ETF PJP | 2.79% | 9.98M | 0.57% |
| 2 | Invesco Biotechnology & Genome ETF PBE | 2.54% | 7.27M | 0.58% |
| 3 | Ballast Small/Mid Cap ETF MGMT | 1.56% | 2.35M | 1.10% |
| 4 | State Street SPDR S&P Pharmaceuticals ETF XPH | 1.49% | 7.03M | 0.35% |
| 5 | ETC 6 Meridian Small Cap Equity ETF SIXS | 0.94% | 1.00M | 0.52% |
| 6 | Invesco S&P SmallCap 600 Revenue ETF RZG | 0.80% | 1.15M | 0.35% |
| 7 | Hartford Multifactor Small Cap ETF ROSC | 0.74% | 452.4K | 0.34% |
| 8 | VictoryShares Small Cap Free Cash Flow ETF SFLO | 0.74% | 4.68M | 0.56% |
| 9 | Distillate Small/Mid Cash Flow ETF DSMC | 0.58% | 765.7K | 0.55% |
| 10 | Harbor Human Capital Factor US Small Cap ETF HAPS | 0.51% | 865.2K | 0.61% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.91
Neutral
Ratio by volume
1.74
Bullish
Buys
10
Sells
11
Shares acquired
288.9K
Shares disposed
165.6K
Cash buys
—
Cash sales
3.00
Net activity
+123,320
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | Dieter David | Officer | S-Sale | D | Common Stock | 13,976 | 34.92 | 488.1K | 77,071 | D | ↗ |
| 2026-03-17 | Dieter David | Officer | F-InKind | D | Common Stock | 8,840 | 35.72 | 315.8K | 68,231 | D | ↗ |
| 2026-03-03 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 46,417 | 40.36 | 1.87M | 75,329 | D | ↗ |
| 2026-02-10 | Tupper Colleen | Officer | F-InKind | D | Common Stock | 26,679 | 46.75 | 1.25M | 147,282 | D | ↗ |
| 2026-02-10 | Smith Thomas B | Officer | A-Award | A | Common Stock | 14,268 | 0.00 | — | 85,312 | D | ↗ |
| 2026-02-10 | Karnani Vikram | Director / Officer | A-Award | A | Common Stock | 79,264 | 0.00 | — | 176,629 | D | ↗ |
| 2026-02-10 | Dreyer Scott | Officer | F-InKind | D | Common Stock | 21,615 | 46.75 | 1.01M | 121,746 | D | ↗ |
| 2026-02-10 | Dieter David | Officer | A-Award | A | Common Stock | 22,194 | 0.00 | — | 91,047 | D | ↗ |
| 2025-12-08 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 6,475 | 48.66 | 315.1K | 103,613 | D | ↗ |
| 2025-12-05 | Balice-Gordon Rita J. | Director | S-Sale | D | Common Stock | 3,650 | 47.03 | 171.7K | 52,629 | D | ↗ |
| 2025-11-12 | Karnani Vikram | Director / Officer | F-InKind | D | Common Stock | 8,983 | 47.35 | 425.3K | 96,989 | D | ↗ |
| 2025-11-12 | Fallon John A. | Director | M-Exempt | A | Common Stock | 19,853 | 9.33 | 185.2K | 99,487 | D | ↗ |
| 2025-11-06 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 25,142 | 40.38 | 1.02M | 131,525 | D | ↗ |
| 2025-08-29 | Smith Thomas B | Officer | S-Sale | D | Common Stock | 17,478 | 38.42 | 671.6K | 70,264 | D | ↗ |
| 2025-08-18 | Dreyer Scott | Officer | M-Exempt | A | Common Stock | 16,389 | 21.34 | 349.7K | 120,002 | D | ↗ |
| 2025-08-15 | SANTINI GINO | Director | M-Exempt | A | Common Stock | 15,000 | 13.45 | 201.8K | 100,447 | D | ↗ |
| 2025-08-13 | Rubric Capital Management LP | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 25,000 | 37.85 | 946.3K | 3,132,743 | I | ↗ |
| 2025-08-13 | Dreyer Scott | Officer | M-Exempt | A | Common Stock | 4,861 | 21.34 | 103.7K | 108,474 | D | ↗ |
| 2025-08-08 | Freund John Gordon | Director | S-Sale | D | Common Stock | 11,659 | 34.36 | 400.6K | 23,129 | I | ↗ |
| 2025-08-07 | Rubric Capital Management LP | 10% Owner | — | — | Common stock, par value $0.001 per share | 0 | 0.00 | — | 3,157,743 | I | ↗ |
| 2025-06-09 | Freund John Gordon | Director | M-Exempt | A | Common Stock | 15,000 | 13.45 | 201.8K | 77,259 | D | ↗ |
| 2025-05-15 | SANTINI GINO | Director | A-Award | A | Common Stock | 9,791 | 0.00 | — | 85,447 | D | ↗ |
| 2025-05-15 | Paya Carlos V | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-15 | Lurker Nancy | Director | A-Award | A | Common Stock | 9,791 | 0.00 | — | 22,517 | D | ↗ |
| 2025-05-15 | Freund John Gordon | Director | A-Award | A | Common Stock | 9,791 | 0.00 | — | 62,259 | D | ↗ |
| 2025-05-15 | Fallon John A. | Director | A-Award | A | Common Stock | 9,791 | 0.00 | — | 64,634 | D | ↗ |
| 2025-05-15 | Balice-Gordon Rita J. | Director | A-Award | A | Common Stock | 9,791 | 0.00 | — | 56,279 | D | ↗ |
| 2025-05-15 | BOHLIN GAREN G | Director | A-Award | A | Common Stock | 9,791 | 0.00 | — | 62,259 | D | ↗ |
| 2025-03-21 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 6,396 | 30.03 | 192.1K | 156,667 | D | ↗ |
| 2025-03-21 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 18,881 | 30.03 | 567.0K | 103,613 | D | ↗ |
| 2025-03-20 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 1,206 | 30.00 | 36.2K | 163,063 | D | ↗ |
| 2025-03-20 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 1,927 | 30.00 | 57.8K | 122,494 | D | ↗ |
| 2025-03-17 | Dieter David | Officer | A-Award | A | Common Stock | 68,449 | 0.00 | — | 68,449 | D | ↗ |
| 2025-03-14 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 977 | 30.00 | 29.3K | 164,269 | D | ↗ |
| 2025-03-14 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 2,255 | 30.00 | 67.7K | 124,421 | D | ↗ |
| 2025-03-11 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 10,445 | 30.01 | 313.4K | 165,246 | D | ↗ |
| 2025-03-11 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 15,387 | 30.00 | 461.7K | 126,676 | D | ↗ |
| 2025-03-07 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 1,504 | 30.00 | 45.1K | 175,691 | D | ↗ |
| 2025-03-07 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 2,348 | 30.00 | 70.4K | 142,063 | D | ↗ |
| 2025-03-06 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 1,949 | 30.00 | 58.5K | 177,195 | D | ↗ |
| 2025-03-06 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 26,067 | 28.50 | 742.9K | 108,137 | D | ↗ |
| 2025-03-06 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 3,295 | 30.00 | 98.9K | 144,411 | D | ↗ |
| 2025-03-05 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 20,000 | 28.03 | 560.5K | 134,204 | D | ↗ |
| 2025-03-04 | Kuhlmann Shirley R. | Officer | M-Exempt | A | Common Stock | 40,000 | 24.03 | 961.2K | 194,204 | D | ↗ |
| 2025-02-10 | Tupper Colleen | Officer | F-InKind | D | Common Stock | 22,317 | 30.52 | 681.1K | 179,144 | D | ↗ |
| 2025-02-10 | Smith Thomas B | Officer | F-InKind | D | Common Stock | 4,399 | 30.52 | 134.3K | 87,742 | D | ↗ |
| 2025-02-10 | Kuhlmann Shirley R. | Officer | A-Award | A | Common Stock | 40,965 | 0.00 | — | 160,149 | D | ↗ |
| 2025-02-10 | Heffernan Michael Thomas | Director | A-Award | A | Common Stock | 4,820 | 0.00 | — | 50,328 | D | ↗ |
| 2025-02-10 | Dreyer Scott | Officer | F-InKind | D | Common Stock | 21,670 | 30.52 | 661.4K | 147,706 | D | ↗ |
| 2025-02-04 | Lurker Nancy | Director | A-Award | A | Common Stock | 12,726 | 0.00 | — | 12,726 | D | ↗ |
| 2025-01-10 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 21,400 | 32.87 | 703.4K | 125,284 | D | ↗ |
| 2024-11-12 | Karnani Vikram | Director / Officer | A-Award | A | Stock Option (Right to Purchase) | 130,344 | 31.41 | 4.09M | 130,344 | D | ↗ |
| 2024-09-13 | Smith Thomas B | Officer | S-Sale | D | Common Stock | 9,593 | 36.62 | 351.3K | 53,816 | — | ↗ |
| 2024-09-06 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 977 | 37.46 | 36.6K | 119,184 | — | ↗ |
| 2024-09-05 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 16,848 | 38.18 | 643.3K | 122,561 | — | ↗ |
| 2024-06-03 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 700 | 33.22 | 23.3K | 139,409 | — | ↗ |
| 2024-05-28 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 19,710 | 34.21 | 674.4K | 130,845 | — | ↗ |
| 2024-05-24 | Dreyer Scott | Officer | M-Exempt | D | Stock Option (Right to Purchase) | 23,791 | 24.03 | 571.7K | 0 | — | ↗ |
| 2024-05-23 | Dreyer Scott | Officer | M-Exempt | D | Stock Option (Right to Purchase) | 51,209 | 24.03 | 1.23M | 23,791 | — | ↗ |
| 2024-05-16 | SANTINI GINO | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 75,656 | — | ↗ |
| 2024-05-16 | Melincoff Gwen A | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 52,468 | — | ↗ |
| 2024-05-16 | McFarlane Neil F. | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 49,365 | — | ↗ |
| 2024-05-16 | Heffernan Michael Thomas | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 45,508 | — | ↗ |
| 2024-05-16 | Freund John Gordon | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 52,468 | — | ↗ |
| 2024-05-16 | Fallon John A. | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 54,843 | — | ↗ |
| 2024-05-16 | Balice-Gordon Rita J. | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 46,488 | — | ↗ |
| 2024-05-16 | BOHLIN GAREN G | Director | A-Award | A | Common Stock | 7,693 | 0.00 | — | 52,468 | — | ↗ |
| 2024-05-14 | BOHLIN GAREN G | Director | M-Exempt | A | Common Stock | 28,985 | 5.73 | 166.1K | 73,760 | — | ↗ |
| 2024-02-29 | Smith Thomas B | Officer | S-Sale | D | Common Stock | 995 | 36.76 | 36.6K | 63,409 | — | ↗ |
| 2024-02-26 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 9,336 | 36.38 | 339.6K | 139,582 | — | ↗ |
| 2024-02-12 | Tupper Colleen | Officer | A-Award | A | Common Stock | 40,600 | 0.00 | — | 146,020 | — | ↗ |
| 2024-02-12 | Smith Thomas B | Officer | F-InKind | D | Common Stock | 1,899 | 33.70 | 64.0K | 65,704 | — | ↗ |
| 2024-02-12 | Kuhlmann Shirley R. | Officer | A-Award | A | Common Stock | 33,247 | 0.00 | — | 196,165 | — | ↗ |
| 2024-02-12 | Dreyer Scott | Officer | A-Award | A | Common Stock | 35,000 | 0.00 | — | 146,322 | — | ↗ |
| 2024-02-12 | Ciaffoni Joseph | Director / Officer | A-Award | A | Common Stock | 179,734 | 0.00 | — | 573,734 | — | ↗ |
| 2024-01-16 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 23,560 | 32.28 | 760.5K | 111,322 | — | ↗ |
| 2023-12-21 | Ciaffoni Joseph | Director / Officer | M-Exempt | D | Stock Option (Right to Purchase) | 4,357 | 21.34 | 93.0K | 16,875 | — | ↗ |
| 2023-12-20 | Ciaffoni Joseph | Director / Officer | M-Exempt | A | Common Stock | 26,454 | 21.34 | 564.5K | 301,454 | — | ↗ |
| 2023-12-19 | Ciaffoni Joseph | Director / Officer | M-Exempt | A | Common Stock | 14,516 | 21.34 | 309.8K | 289,516 | — | ↗ |
| 2023-12-18 | Ciaffoni Joseph | Director / Officer | M-Exempt | A | Common Stock | 27,798 | 21.34 | 593.2K | 302,798 | — | ↗ |
| 2023-11-27 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 25,600 | 25.78 | 660.0K | 119,518 | — | ↗ |
| 2023-06-26 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 1,363 | 22.53 | 30.7K | 119,518 | — | ↗ |
| 2023-06-02 | Ciaffoni Joseph | Director / Officer | S-Sale | D | Common Stock | 30,272 | 21.58 | 653.2K | 276,000 | — | ↗ |
| 2023-06-01 | Ciaffoni Joseph | Director / Officer | S-Sale | D | Common Stock | 31,272 | 22.09 | 690.8K | 306,272 | — | ↗ |
| 2023-05-31 | Ciaffoni Joseph | Director / Officer | S-Sale | D | Common Stock | 31,272 | 21.87 | 683.8K | 337,544 | — | ↗ |
| 2023-05-30 | Ciaffoni Joseph | Director / Officer | S-Sale | D | Common Stock | 31,271 | 21.90 | 684.9K | 368,816 | — | ↗ |
| 2023-05-18 | SANTINI GINO | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 67,963 | — | ↗ |
| 2023-05-18 | Melincoff Gwen A | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 44,775 | — | ↗ |
| 2023-05-18 | McFarlane Neil F. | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 41,672 | — | ↗ |
| 2023-05-18 | Heffernan Michael Thomas | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 37,815 | — | ↗ |
| 2023-05-18 | Freund John Gordon | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 44,775 | — | ↗ |
| 2023-05-18 | Fallon John A. | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 47,150 | — | ↗ |
| 2023-05-18 | Balice-Gordon Rita J. | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 38,795 | — | ↗ |
| 2023-05-18 | BOHLIN GAREN G | Director | A-Award | A | Common Stock | 9,792 | 0.00 | — | 44,775 | — | ↗ |
| 2023-03-15 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 31,640 | 23.77 | 752.2K | 105,420 | — | ↗ |
| 2023-03-01 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 13,324 | 26.70 | 355.8K | 134,882 | — | ↗ |
| 2023-02-13 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 21,811 | 26.88 | 586.3K | 137,502 | — | ↗ |
| 2023-02-13 | Ciaffoni Joseph | Director / Officer | S-Sale | D | Common Stock | 11,250 | 26.88 | 302.4K | 400,087 | — | ↗ |
| 2023-02-10 | Tupper Colleen | Officer | A-Award | A | Common Stock | 45,045 | 0.00 | — | 135,349 | — | ↗ |
| 2023-02-10 | Smith Thomas B | Officer | A-Award | A | Common Stock | 31,185 | 0.00 | — | 31,185 | — | ↗ |
| 2023-02-10 | Kuhlmann Shirley R. | Officer | A-Award | A | Common Stock | 48,125 | 0.00 | — | 157,620 | — | ↗ |
| 2023-02-10 | Dreyer Scott | Officer | A-Award | A | Common Stock | 22,459 | 0.00 | — | 169,532 | — | ↗ |
| 2023-02-10 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 59,736 | 26.75 | 1.60M | 400,087 | — | ↗ |
| 2023-01-09 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 10,424 | 27.08 | 282.3K | 110,208 | — | ↗ |
| 2022-12-27 | Heffernan Michael Thomas | Director | S-Sale | D | Common Stock | 3,820 | 24.16 | 92.3K | 28,023 | — | ↗ |
| 2022-12-27 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 1,804 | 23.65 | 42.7K | 249,150 | — | ↗ |
| 2022-12-23 | Heffernan Michael Thomas | Director | M-Exempt | D | Stock Option (Right to Purchase) | 4,989 | 0.00 | — | 19,815 | — | ↗ |
| 2022-12-23 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 147 | 23.00 | 3.4K | 250,954 | — | ↗ |
| 2022-12-22 | Heffernan Michael Thomas | Director | M-Exempt | A | Common Stock | 237 | 16.15 | 3.8K | 28,260 | — | ↗ |
| 2022-12-22 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 110 | 23.00 | 2.5K | 251,101 | — | ↗ |
| 2022-12-21 | Heffernan Michael Thomas | Director | S-Sale | D | Common Stock | 46,600 | 23.11 | 1.08M | 28,023 | — | ↗ |
| 2022-12-21 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 7,333 | 23.11 | 169.5K | 251,211 | — | ↗ |
| 2022-12-20 | Heffernan Michael Thomas | Director | M-Exempt | D | Stock Option (Right to Purchase) | 33,758 | 0.00 | — | 71,641 | — | ↗ |
| 2022-12-20 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 9,375 | 23.07 | 216.3K | 258,544 | — | ↗ |
| 2022-12-19 | Heffernan Michael Thomas | Director | M-Exempt | A | Common Stock | 3,606 | 16.15 | 58.2K | 31,629 | — | ↗ |
| 2022-12-19 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 1,134 | 23.01 | 26.1K | 267,919 | — | ↗ |
| 2022-12-13 | Heffernan Michael Thomas | Director | M-Exempt | D | Stock Option (Right to Purchase) | 7,904 | 0.00 | — | 0 | — | ↗ |
| 2022-12-12 | Heffernan Michael Thomas | Director | M-Exempt | A | Common Stock | 10,669 | 14.90 | 159.0K | 38,692 | — | ↗ |
| 2022-12-02 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 54,400 | 23.07 | 1.26M | 269,053 | — | ↗ |
| 2022-12-01 | Ciaffoni Joseph | Officer | M-Exempt | A | Common Stock | 76,653 | 15.90 | 1.22M | 400,106 | — | ↗ |
| 2022-11-28 | Ciaffoni Joseph | Officer | M-Exempt | A | Common Stock | 43 | 15.90 | 683.70 | 323,496 | — | ↗ |
| 2022-11-22 | Ciaffoni Joseph | Officer | S-Sale | D | Common Stock | 65 | 22.00 | 1.4K | 323,453 | — | ↗ |
| 2022-11-18 | Ciaffoni Joseph | Director / Officer | M-Exempt | A | Common Stock | 1,989 | 15.90 | 31.6K | 325,442 | — | ↗ |
| 2022-10-04 | Tupper Colleen | Officer | S-Sale | D | Common Stock | 4,350 | 17.35 | 75.5K | 90,304 | — | ↗ |
| 2022-09-15 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 38,589 | 18.07 | 697.3K | 109,495 | — | ↗ |
| 2022-08-11 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 300 | 20.01 | 6.0K | 148,084 | — | ↗ |
| 2022-07-11 | Dreyer Scott | Officer | F-InKind | D | Common Stock | 594 | 17.48 | 10.4K | 120,632 | — | ↗ |
| 2022-07-01 | Ciaffoni Joseph | Officer | F-InKind | D | Common Stock | 1,394 | 18.16 | 25.3K | 323,453 | — | ↗ |
| 2022-05-19 | SANTINI GINO | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 58,171 | — | ↗ |
| 2022-05-19 | Melincoff Gwen A | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 34,983 | — | ↗ |
| 2022-05-19 | McFarlane Neil F. | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 31,880 | — | ↗ |
| 2022-05-19 | Heffernan Michael Thomas | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 28,023 | — | ↗ |
| 2022-05-19 | Freund John Gordon | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 34,983 | — | ↗ |
| 2022-05-19 | Fallon John A. | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 37,358 | — | ↗ |
| 2022-05-19 | Balice-Gordon Rita J. | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 29,003 | — | ↗ |
| 2022-05-19 | BOHLIN GAREN G | Director | A-Award | A | Common Stock | 14,035 | 0.00 | — | 34,983 | — | ↗ |
| 2022-04-06 | McFarlane Neil F. | Director | — | D | No securities beneficially owned | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-23 | Smith Thomas B | Officer | — | D | No securities beneficially owned | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-16 | Kuhlmann Shirley R. | Officer | F-InKind | D | Common Stock | 734 | 18.99 | 13.9K | 148,384 | — | ↗ |
| 2022-03-01 | Ciaffoni Joseph | Director / Officer | S-Sale | D | Common Stock | 65,083 | 18.37 | 1.20M | 335,858 | — | ↗ |
| 2022-02-18 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 10,559 | 21.61 | 228.2K | 121,226 | — | ↗ |
| 2022-02-10 | Tupper Colleen | Officer | A-Award | A | Common Stock | 52,500 | 0.00 | — | 94,500 | — | ↗ |
| 2022-02-10 | Malamut Richard | Officer | F-InKind | D | Common Stock | 1,838 | 17.63 | 32.4K | 130,264 | — | ↗ |
| 2022-02-10 | Kuhlmann Shirley R. | Officer | F-InKind | D | Common Stock | 4,212 | 17.63 | 74.3K | 149,118 | — | ↗ |
| 2022-02-10 | Dreyer Scott | Officer | A-Award | A | Common Stock | 13,675 | 0.00 | — | 142,444 | — | ↗ |
| 2022-02-10 | Ciaffoni Joseph | Director / Officer | A-Award | A | Common Stock | 65,034 | 0.00 | — | 453,938 | — | ↗ |
| 2022-01-10 | Dreyer Scott | Officer | F-InKind | D | Common Stock | 701 | 19.05 | 13.4K | 76,269 | — | ↗ |
| 2022-01-03 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 1,090 | 18.68 | 20.4K | 263,904 | — | ↗ |
| 2021-12-15 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 5,693 | 18.33 | 104.4K | 76,970 | — | ↗ |
| 2021-09-16 | Kuhlmann Shirley R. | Officer | F-InKind | D | Common Stock | 734 | 19.67 | 14.4K | 89,256 | — | ↗ |
| 2021-08-10 | Fleming Alison B | Officer | F-InKind | D | Common Stock | 1,386 | 19.03 | 26.4K | 143,694 | — | ↗ |
| 2021-08-10 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 1,386 | 19.03 | 26.4K | 264,994 | — | ↗ |
| 2021-07-12 | Dreyer Scott | Officer | F-InKind | D | Common Stock | 595 | 23.17 | 13.8K | 82,663 | — | ↗ |
| 2021-07-01 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 1,394 | 23.99 | 33.4K | 266,380 | — | ↗ |
| 2021-06-02 | Ciaffoni Joseph | Director / Officer | S-Sale | D | Common Stock | 5,861 | 22.81 | 133.7K | 267,774 | — | ↗ |
| 2021-06-01 | Ciaffoni Joseph | Director / Officer | M-Exempt | A | Common Stock | 16,205 | 8.22 | 133.2K | 289,840 | — | ↗ |
| 2021-05-24 | Tupper Colleen | Officer | — | D | No securities beneficially owned | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-05-20 | SANTINI GINO | Director | A-Award | A | Common Stock | 9,941 | 0.00 | — | 44,136 | — | ↗ |
| 2021-05-20 | Melincoff Gwen A | Director | A-Award | A | Common Stock | 9,941 | 0.00 | — | 20,948 | — | ↗ |
| 2021-05-20 | Heffernan Michael Thomas | Director | A-Award | A | Common Stock | 9,941 | 0.00 | — | 13,988 | — | ↗ |
| 2021-05-20 | Freund John Gordon | Director | A-Award | A | Common Stock | 9,941 | 0.00 | — | 20,948 | — | ↗ |
| 2021-05-20 | Fallon John A. | Director | A-Award | A | Common Stock | 9,941 | 0.00 | — | 23,323 | — | ↗ |
| 2021-05-20 | Balice-Gordon Rita J. | Director | A-Award | A | Common Stock | 9,941 | 0.00 | — | 14,968 | — | ↗ |
| 2021-05-20 | BOHLIN GAREN G | Director | A-Award | A | Common Stock | 9,941 | 0.00 | — | 20,948 | — | ↗ |
| 2021-05-10 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 7,000 | 22.77 | 159.4K | 89,990 | — | ↗ |
| 2021-04-01 | Malamut Richard | Officer | F-InKind | D | Common Stock | 3,119 | 23.38 | 72.9K | 93,558 | — | ↗ |
| 2021-04-01 | Fleming Alison B | Officer | F-InKind | D | Common Stock | 1,757 | 23.38 | 41.1K | 152,980 | — | ↗ |
| 2021-03-30 | Fleming Alison B | Officer | A-Award | A | Common Stock | 5,984 | 0.00 | — | 154,737 | — | ↗ |
| 2021-03-16 | Kuhlmann Shirley R. | Officer | F-InKind | D | Common Stock | 734 | 24.69 | 18.1K | 96,990 | — | ↗ |
| 2021-03-15 | Heffernan Michael Thomas | Director | S-Sale | D | Common Stock | 47,044 | 25.26 | 1.19M | 7,078 | — | ↗ |
| 2021-03-01 | Fleming Alison B | Officer | S-Sale | D | Common Stock | 6,011 | 23.36 | 140.4K | 148,753 | — | ↗ |
| 2021-03-01 | Ciaffoni Joseph | Director / Officer | M-Exempt | D | Stock Option (Right to Purchase) | 48,616 | 8.22 | 399.6K | 16,205 | — | ↗ |
| 2021-02-11 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 2,100 | 24.89 | 52.3K | 89,056 | — | ↗ |
| 2021-02-10 | Malamut Richard | Officer | F-InKind | D | Common Stock | 1,542 | 25.95 | 40.0K | 96,677 | — | ↗ |
| 2021-02-10 | Kuhlmann Shirley R. | Officer | F-InKind | D | Common Stock | 3,695 | 25.95 | 95.9K | 97,724 | — | ↗ |
| 2021-02-10 | Fleming Alison B | Officer | F-InKind | D | Common Stock | 5,045 | 25.95 | 130.9K | 156,164 | — | ↗ |
| 2021-02-10 | Dreyer Scott | Officer | F-InKind | D | Common Stock | 3,283 | 25.95 | 85.2K | 91,156 | — | ↗ |
| 2021-02-10 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 8,498 | 25.95 | 220.5K | 309,747 | — | ↗ |
| 2021-02-10 | Brannelly Paul | Officer | F-InKind | D | Common Stock | 2,564 | 25.95 | 66.5K | 221,355 | — | ↗ |
| 2021-01-20 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 6,081 | 24.45 | 148.7K | 103,582 | D | ↗ |
| 2021-01-19 | Malamut Richard | Officer | A-Award | A | Stock Option (Right to Purchase) | 105,600 | 24.06 | 2.54M | 105,600 | D | ↗ |
| 2021-01-19 | Kuhlmann Shirley R. | Officer | A-Award | A | Stock Option (Right to Purchase) | 129,600 | 24.06 | 3.12M | 129,600 | D | ↗ |
| 2021-01-19 | Fleming Alison B | Officer | A-Award | A | Stock Option (Right to Purchase) | 129,600 | 24.06 | 3.12M | 129,600 | D | ↗ |
| 2021-01-19 | Dreyer Scott | Officer | A-Award | A | Stock Option (Right to Purchase) | 130,800 | 24.06 | 3.15M | 130,800 | D | ↗ |
| 2021-01-19 | Ciaffoni Joseph | Director / Officer | A-Award | A | Stock Option (Right to Purchase) | 420,000 | 24.06 | 10.11M | 420,000 | — | ↗ |
| 2021-01-19 | Brannelly Paul | Officer | A-Award | A | Stock Option (Right to Purchase) | 120,000 | 24.06 | 2.89M | 120,000 | D | ↗ |
| 2021-01-15 | Dreyer Scott | Officer | S-Sale | D | Common Stock | 1,322 | 22.89 | 30.3K | 44,395 | — | ↗ |
| 2021-01-11 | Dreyer Scott | Officer | F-InKind | D | Common Stock | 701 | 21.18 | 14.8K | 45,717 | — | ↗ |
| 2021-01-07 | Fleming Alison B | Officer | M-Exempt | A | Common Stock | 16,042 | 5.73 | 91.9K | 127,461 | — | ↗ |
| 2021-01-04 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 1,090 | 20.03 | 21.8K | 184,256 | — | ↗ |
| 2020-12-03 | Fleming Alison B | Officer | S-Sale | D | Common Stock | 5,967 | 19.24 | 114.8K | 111,419 | — | ↗ |
| 2020-11-30 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 4,672 | 18.49 | 86.4K | 185,346 | — | ↗ |
| 2020-11-18 | Fleming Alison B | Officer | M-Exempt | A | Common Stock | 16,000 | 5.73 | 91.7K | 117,386 | — | ↗ |
| 2020-10-15 | Kuhlmann Shirley R. | Officer | S-Sale | D | Common Stock | 7,060 | 20.82 | 147.0K | 57,531 | — | ↗ |
| 2020-09-24 | Balice-Gordon Rita J. | Director | A-Award | A | Common Stock | 5,027 | 0.00 | — | 5,027 | — | ↗ |
| 2020-09-16 | Kuhlmann Shirley R. | Officer | F-InKind | D | Common Stock | 734 | 19.33 | 14.2K | 64,591 | — | ↗ |
| 2020-08-11 | Heffernan Michael Thomas | Director | S-Sale | D | Common Stock | 13,071 | 19.13 | 250.0K | 54,122 | — | ↗ |
| 2020-08-10 | Fleming Alison B | Officer | F-InKind | D | Common Stock | 1,515 | 18.89 | 28.6K | 101,386 | — | ↗ |
| 2020-08-10 | Ciaffoni Joseph | Director / Officer | F-InKind | D | Common Stock | 1,386 | 18.89 | 26.2K | 190,018 | — | ↗ |
| 2020-08-10 | Brannelly Paul | Officer | F-InKind | D | Common Stock | 1,515 | 18.89 | 28.6K | 173,758 | — | ↗ |
Executive team
Top executives
EBIT / Employee
490.0K
Shares Outstanding
32.41M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | David Dieter Executive Vice President and General Counsel | 384.6K | — | 3.19M | — | 277.2K | 18.6K | 3.87M | 82.42% | ↗ |
| 2 | 2025 | Colleen Tupper Executive Vice President and Chief Financial Officer | 559.3K | — | 2.48M | — | 449.3K | 21.9K | 3.52M | 70.68% | ↗ |
| 3 | 2025 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 523.2K | — | 2.16M | — | 335.6K | 21.9K | 3.04M | 71.04% | ↗ |
| 4 | 2025 | Shirley Kuhlmann Former Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 115.5K | — | 1.97M | — | — | 702.0K | 2.78M | 70.63% | ↗ |
| 5 | 2025 | Thomas Smith, M.D. Executive Vice President and Chief Medical Officer | 493.0K | — | 1.62M | — | 315.2K | 17.5K | 2.45M | 66.24% | ↗ |
| 6 | 2025 | Vikram Karnani President and Chief Executive Officer | 875.0K | — | — | — | 835.4K | 5.4K | 1.72M | 0.00% | ↗ |
| 7 | 2024 | Vikram Karnani President and Chief Executive Officer | 97.6K | 500.0K | 7.82M | 2.23M | 130.7K | 124.00 | 10.78M | 93.24% | ↗ |
| 8 | 2024 | Joseph Ciaffoni Former President and Chief Executive Officer | 364.4K | — | 9.37M | — | — | 952.5K | 10.69M | 87.68% | ↗ |
| 9 | 2024 | Shirley Kuhlmann Former Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 525.3K | 30.0K | 2.30M | — | 423.0K | 22.2K | 3.30M | 69.69% | ↗ |
| 10 | 2024 | Colleen Tupper Executive Vice President and Chief Financial Officer | 514.7K | 30.0K | 2.15M | — | 470.7K | 22.2K | 3.19M | 67.47% | ↗ |
| 11 | 2024 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 489.5K | 30.0K | 1.86M | — | 394.3K | 22.2K | 2.79M | 66.47% | ↗ |
| 12 | 2024 | Thomas Smith, M.D. Executive Vice President and Chief Medical Officer | 473.5K | 30.0K | 1.63M | — | 346.1K | 17.7K | 2.50M | 65.31% | ↗ |
| 13 | 2024 | Michael Heffernan, R.Ph. Former Interim President and Chief Executive Officer | 135.7K | — | 259.0K | — | — | 71.7K | 466.5K | 55.53% | ↗ |
| 14 | 2023 | Joseph Ciaffoni Former President and Chief Executive Officer | 817.0K | — | 7.69M | — | 612.6K | 22.0K | 9.14M | 84.12% | ↗ |
| 15 | 2023 | Joseph Ciaffoni President and Chief Executive Officer | 817.0K | — | 7.69M | — | 612.6K | 22.0K | 9.14M | 84.12% | ↗ |
| 16 | 2023 | Shirley Kuhlmann Executive Vice President, Chief Administrative Officer, General Counsel & Secretary | 490.4K | — | 2.09M | — | 278.4K | 19.6K | 2.87M | 72.57% | ↗ |
| 17 | 2023 | Shirley Kuhlmann Former Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 490.4K | — | 2.09M | — | 278.4K | 19.6K | 2.87M | 72.57% | ↗ |
| 18 | 2023 | Colleen Tupper Executive Vice President and Chief Financial Officer | 485.6K | — | 1.95M | — | 275.1K | 22.0K | 2.73M | 71.38% | ↗ |
| 19 | 2023 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 462.3K | — | 1.92M | — | 209.3K | 22.0K | 2.61M | 73.45% | ↗ |
| 20 | 2023 | Thomas Smith, M.D. Executive Vice President and Chief Medical Officer | 451.4K | — | 1.35M | — | 224.2K | 17.6K | 2.04M | 66.10% | ↗ |
| 21 | 2022 | Joseph Ciaffoni President and Chief Executive Officer | 751.8K | — | 5.23M | — | 914.3K | 19.6K | 6.92M | 75.63% | ↗ |
| 22 | 2022 | Joseph Ciaffoni Former President and Chief Executive Officer | 751.8K | — | 5.23M | — | 914.3K | 19.6K | 6.92M | 75.63% | ↗ |
| 23 | 2022 | Shirley Kuhlmann Former Executive Vice President, Chief Administrative Officer, General Counsel and Secretary | 455.0K | — | 1.59M | — | 369.3K | 18.6K | 2.43M | 65.33% | ↗ |
| 24 | 2022 | Shirley Kuhlmann Executive Vice President, Chief Administrative Officer, General Counsel & Secretary | 455.0K | — | 1.59M | — | 369.3K | 18.6K | 2.43M | 65.33% | ↗ |
| 25 | 2022 | Colleen Tupper Executive Vice President and Chief Financial Officer | 458.1K | — | 1.47M | — | 371.8K | 18.4K | 2.32M | 63.42% | ↗ |
| 26 | 2022 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 440.3K | — | 1.47M | — | 285.5K | 20.8K | 2.22M | 66.33% | ↗ |
| 27 | 2022 | Richard Malamut, M.D. Former Executive Vice President and Chief Medical Officer | 119.4K | — | 1.03M | — | — | 515.4K | 1.66M | 61.86% | ↗ |
| 28 | 2022 | Thomas Smith, M.D. Executive Vice President and Chief Medical Officer | 318.6K | — | — | — | 281.2K | 682.00 | 600.5K | 0.00% | ↗ |
| 29 | 2021 | Joseph Ciaffoni President and Chief Executive Officer | 712.8K | — | 6.21M | — | 369.4K | 17.9K | 7.31M | 84.96% | ↗ |
| 30 | 2021 | Shirley Kuhlmann Executive Vice President, Chief Administrative Officer, General Counsel & Secretary | 429.7K | — | 1.77M | — | 174.2K | 16.2K | 2.39M | 74.10% | ↗ |
| 31 | 2021 | Shirley Kuhlmann Executive Vice President, General Counsel and Chief Administrative Officer | 429.7K | — | 1.77M | — | 174.2K | 16.2K | 2.39M | 74.10% | ↗ |
| 32 | 2021 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 418.6K | — | 1.79M | — | 154.5K | 17.9K | 2.38M | 75.18% | ↗ |
| 33 | 2021 | Colleen Tupper Executive Vice President and Chief Financial Officer | 259.3K | 250.0K | 1.67M | — | 106.3K | 15.6K | 2.30M | 72.55% | ↗ |
| 34 | 2021 | Alison Fleming, Ph.D. Former Executive Vice President and Chief Technology Officer | 299.5K | — | 1.77M | — | — | 24.2K | 2.10M | 84.57% | ↗ |
| 35 | 2021 | Richard Malamut, M.D. Former Executive Vice President and Chief Medical Officer | 434.5K | — | 1.45M | — | 159.8K | 17.9K | 2.06M | 70.25% | ↗ |
| 36 | 2021 | Paul Brannelly Former Executive Vice President and Chief Financial Officer | 183.2K | — | 1.64M | — | — | 19.0K | 1.84M | 89.04% | ↗ |
| 37 | 2020 | Joseph Ciaffoni President and Chief Executive Officer | 654.3K | — | 3.76M | 1.15M | 460.0K | 17.7K | 6.04M | 81.27% | ↗ |
| 38 | 2020 | Alison Fleming, Ph.D. Former Executive Vice President and Chief Technology Officer | 377.7K | — | 1.54M | 320.8K | 189.3K | 13.3K | 2.44M | 76.21% | ↗ |
| 39 | 2020 | Alison Fleming, Ph.D. Executive Vice President and Chief Technical Officer | 377.7K | — | 1.54M | 320.8K | 189.3K | 13.3K | 2.44M | 76.21% | ↗ |
| 40 | 2020 | Paul Brannelly Former Executive Vice President and Chief Financial Officer | 438.0K | 50.0K | 1.21M | 401.0K | 220.0K | 17.7K | 2.34M | 68.98% | ↗ |
| 41 | 2020 | Paul Brannelly Executive Vice President and Chief Financial Officer | 438.0K | 50.0K | 1.21M | 401.0K | 220.0K | 17.7K | 2.34M | 68.98% | ↗ |
| 42 | 2020 | Shirley Kuhlmann Executive Vice President, Chief Administrative Officer, General Counsel & Secretary | 410.1K | 50.0K | 1.06M | 352.9K | 205.8K | 16.2K | 2.10M | 67.46% | ↗ |
| 43 | 2020 | Shirley Kuhlmann Executive Vice President, General Counsel and Chief Administrative Officer | 410.1K | 50.0K | 1.06M | 352.9K | 205.8K | 16.2K | 2.10M | 67.46% | ↗ |
| 44 | 2020 | Shirley Kuhlmann Executive Vice President and General Counsel | 410.1K | 50.0K | 1.06M | 352.9K | 205.8K | 16.2K | 2.10M | 67.46% | ↗ |
| 45 | 2020 | Richard Malamut, M.D. Former Executive Vice President and Chief Medical Officer | 422.7K | — | 821.0K | 288.7K | 211.7K | 17.7K | 1.76M | 62.99% | ↗ |
| 46 | 2020 | Richard Malamut, M.D. Executive Vice President and Chief Medical Officer | 422.7K | — | 821.0K | 288.7K | 211.7K | 17.7K | 1.76M | 62.99% | ↗ |
| 47 | 2020 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 395.0K | — | 833.1K | 272.7K | 198.0K | 17.7K | 1.72M | 64.42% | ↗ |
| 48 | 2019 | Joseph Ciaffoni President and Chief Executive Officer | 618.5K | — | 2.15M | 859.7K | 390.6K | 17.3K | 4.03M | 74.55% | ↗ |
| 49 | 2019 | Richard Malamut, M.D. Executive Vice President and Chief Medical Officer | 311.3K | — | 642.6K | 765.2K | 186.8K | 17.0K | 1.92M | 73.21% | ↗ |
| 50 | 2019 | Richard Malamut, M.D. Former Executive Vice President and Chief Medical Officer | 311.3K | — | 642.6K | 765.2K | 186.8K | 17.0K | 1.92M | 73.21% | ↗ |
| 51 | 2019 | Paul Brannelly Executive Vice President and Chief Financial Officer | 413.1K | — | 763.2K | 305.7K | 214.8K | 17.0K | 1.71M | 62.37% | ↗ |
| 52 | 2019 | Paul Brannelly Former Executive Vice President and Chief Financial Officer | 413.1K | — | 763.2K | 305.7K | 214.8K | 17.0K | 1.71M | 62.37% | ↗ |
| 53 | 2019 | Shirley Kuhlmann Executive Vice President and General Counsel | 392.4K | — | 610.6K | 244.5K | 186.1K | 15.8K | 1.45M | 59.00% | ↗ |
| 54 | 2019 | Shirley Kuhlmann Executive Vice President, General Counsel and Chief Administrative Officer | 392.4K | — | 610.6K | 244.5K | 186.1K | 15.8K | 1.45M | 59.00% | ↗ |
| 55 | 2019 | Alison Fleming, Ph.D. Former Executive Vice President and Chief Technology Officer | 366.2K | — | 610.6K | 244.5K | 165.4K | 12.9K | 1.40M | 61.10% | ↗ |
| 56 | 2019 | Alison Fleming, Ph.D. Executive Vice President and Chief Technical Officer | 366.2K | — | 610.6K | 244.5K | 165.4K | 12.9K | 1.40M | 61.10% | ↗ |
| 57 | 2019 | Alison Fleming Executive Vice President and Chief Technology Officer | 366.2K | — | 610.6K | 244.5K | 165.4K | 12.9K | 1.40M | 61.10% | ↗ |
| 58 | 2019 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 383.7K | — | 610.6K | 244.5K | 138.4K | 17.3K | 1.39M | 61.32% | ↗ |
| 59 | 2018 | Michael Heffernan, R.Ph. Founder and Chairman | 317.3K | — | 1.83M | 2.22M | 222.5K | 60.2K | 4.64M | 87.08% | ↗ |
| 60 | 2018 | Joseph Ciaffoni President and Chief Executive Officer | 535.6K | 50.0K | 1.21M | 1.35M | 340.9K | 17.3K | 3.51M | 73.08% | ↗ |
| 61 | 2018 | Scott Dreyer Executive Vice President and Chief Commercial Officer | 356.7K | — | 307.9K | 1.11M | 184.6K | 17.1K | 1.98M | 71.75% | ↗ |
| 62 | 2018 | Paul Brannelly Executive Vice President and Chief Financial Officer | 387.7K | — | 608.8K | 739.3K | 222.5K | 17.3K | 1.98M | 68.24% | ↗ |
| 63 | 2018 | Alison Fleming, Ph.D. Executive Vice President and Chief Technical Officer | 346.2K | — | 608.8K | 739.3K | 199.7K | 15.3K | 1.91M | 70.61% | ↗ |
| 64 | 2018 | Alison Fleming Executive Vice President and Chief Technology Officer | 346.2K | — | 608.8K | 739.3K | 199.7K | 15.3K | 1.91M | 70.61% | ↗ |
| 65 | 2018 | Shirley Kuhlmann Executive Vice President and General Counsel | 297.1K | 50.0K | 480.6K | 602.3K | 171.2K | 5.8K | 1.61M | 67.39% | ↗ |
| 66 | 2017 | Michael Heffernan, R.Ph. Founder and Chairman | 546.6K | — | 839.9K | 1.09M | 346.8K | 17.6K | 2.84M | 67.95% | ↗ |
| 67 | 2017 | Michael T. Heffernan, R.Ph. President and Chief Executive Officer | 546.6K | — | 839.9K | 1.09M | 346.8K | 17.6K | 2.84M | 67.95% | ↗ |
| 68 | 2017 | Joseph Ciaffoni President and Chief Executive Officer | 264.8K | — | 692.7K | 1.36M | 147.9K | 15.6K | 2.48M | 82.75% | ↗ |
| 69 | 2017 | Joseph J. Ciaffoni Executive Vice President and Chief Operating Officer | 264.8K | — | 692.7K | 1.36M | 147.9K | 15.6K | 2.48M | 82.75% | ↗ |
| 70 | 2017 | Paul Brannelly Executive Vice President and Chief Financial Officer | 358.2K | — | 248.1K | 323.4K | 149.1K | 17.6K | 1.10M | 52.13% | ↗ |
| 71 | 2017 | Paul J. Brannelly Executive Vice President and Chief Financial Officer | 358.2K | — | 248.1K | 323.4K | 149.1K | 17.6K | 1.10M | 52.13% | ↗ |
| 72 | 2017 | Alison Fleming Executive Vice President and Chief Technology Officer | 296.2K | — | 248.1K | 323.4K | 124.3K | 15.6K | 1.01M | 56.73% | ↗ |
| 73 | 2016 | Michael Heffernan, R.Ph. Founder and Chairman | 502.8K | — | 290.6K | 1.17M | 221.3K | 11.9K | 2.20M | 66.51% | ↗ |
| 74 | 2016 | Michael T. Heffernan, R.Ph. President and Chief Executive Officer | 502.8K | — | 290.6K | 1.17M | 221.3K | 11.9K | 2.20M | 66.51% | ↗ |
| 75 | 2016 | Paul Brannelly Executive Vice President and Chief Financial Officer | 336.1K | — | 78.7K | 317.4K | 107.4K | 8.5K | 848.2K | 46.70% | ↗ |
| 76 | 2016 | Paul J. Brannelly Executive Vice President and Chief Financial Officer | 336.1K | — | 78.7K | 317.4K | 107.4K | 8.5K | 848.2K | 46.70% | ↗ |
| 77 | 2016 | Barry S. Duke Executive Vice President and Chief Commercial Officer | 334.6K | — | 78.7K | 317.0K | 102.1K | 1.3K | 833.8K | 47.47% | ↗ |
| 78 | 2016 | Alison Fleming Executive Vice President and Chief Technology Officer | 247.1K | — | 79.3K | 319.8K | 79.8K | 10.7K | 736.8K | 54.17% | ↗ |
| 79 | 2015 | Michael T. Heffernan, R.Ph. President and Chief Executive Officer | 462.2K | 375.0K | 634.0K | 1.78M | 238.3K | 14.2K | 3.50M | 68.87% | ↗ |
| 80 | 2015 | Paul Brannelly Executive Vice President and Chief Financial Officer | 289.0K | — | — | 624.0K | 111.8K | 4.2K | 1.03M | 60.64% | ↗ |
| 81 | 2015 | Barry S. Duke Executive Vice President and Chief Commercial Officer | 250.0K | — | — | 557.9K | 127.7K | 76.4K | 1.01M | 55.13% | ↗ |
| 82 | 2014 | Michael T. Heffernan, R.Ph. President and Chief Executive Officer | 380.4K | — | — | — | 130.9K | 7.6K | 518.8K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vikram Karnani | President, Chief Executive Officer & Director | 2M | male |
| Colleen Tupper | Executive Vice President & Chief Financial Officer | 1M | female |
| Scott Dreyer | Executive Vice President & Chief Commercial Officer | 880.7K | male |
| Thomas Smith FAAFP | Executive Vice President & Chief Medical Officer | 825.7K | — |
| David Dieter | Executive Vice President, General Counsel & Corporate Secretary | 782.3K | male |
| Jessica Cotrone | Senior Vice President of Communications & Corporate Affairs | — | female |
| Jane Gonnerman | Executive Vice President of Strategy & Corporate Development | — | female |
| Scott Sudduth | EVP & Head of Technical Operations | — | male |
| Ian Karp | Head of Investor Relations | — | male |
| Dean J. Patras | Chief People Officer | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COLL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
